Gene Editing for Vaccine Development


Gene editing technology is being explored as a tool for vaccine development. Techniques such as CRISPR-Cas9 can be used to modify the genetic material of viruses or bacteria to create attenuated or inactivated vaccines. This approach can potentially lead to safer and more effective vaccines, as it allows for precise control over the genetic makeup of the vaccine. Additionally, gene editing can be used to engineer immune cells to enhance their ability to recognize and destroy pathogenic cells. While still in its early stages, the potential of gene editing for vaccine development is a promising area of research that could transform the field of immunology.


    Related Conference of Gene Editing for Vaccine Development

    October 31-01, 2024

    36th International Conference on Vaccines and Immunization

    Amsterdam, Netherlands
    November 28-29, 2024

    6th World Congress on Vaccine and Immunology

    Paris, France
    December 05-06, 2024

    36th Annual Congress on Vaccine and Clinical Trials

    Vancouver, Canada
    February 27-28, 2025

    8th International Conference on Vaccines and Immunology

    Paris, France
    April 28-29, 2025

    2nd Global Summit on Vaccines & Emerging Diseases

    Bali, Indonesia

    Gene Editing for Vaccine Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in